Hyliion insider plans sale of 220,000 shares under Rule 144
Hyliion Holdings Corp. reported that an affiliated holder plans to sell 220,000 shares of its common stock through UBS Financial Services Inc., with an aggregate market value of $432,000, on or about 12/12/2025 on the NYSE.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Hyliion Holdings Corp. reported that an affiliated holder plans to sell 220,000 shares of its common stock through UBS Financial Services Inc., with an aggregate market value of $432,000, on or about 12/12/2025 on the NYSE. The filing notes that Hyliion common stock outstanding was 175,400,000 shares.
The shares to be sold were acquired on 12/12/2025 in an employee benefit transaction from Hyliion Holdings Corp., with cash listed as the form of payment. The disclosure also records that Thomas Healy sold 159,776 common shares on 11/17/2025 for gross proceeds of $265,300 during the prior three months.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What does the Form 144 filing for Hyliion (HYLN) disclose?
The notice states that an affiliated holder of Hyliion Holdings Corp. plans to sell 220,000 shares of Hyliion common stock, with an aggregate market value of $432,000, on or about 12/12/2025 on the NYSE.
What prior Hyliion (HYLN) stock sales are disclosed in the last three months?
The document reports that 159,776 Hyliion common shares were sold by Thomas Healy on 11/17/2025, generating gross proceeds of $265,300.
AI-generated analysis. How Rhea-AI works. Not financial advice.